IGC Pharma
IGC
#10654
Rank
S$37.16 M
Marketcap
S$0.36
Share price
-1.75%
Change (1 day)
-31.95%
Change (1 year)
India Globalization Capital, Inc. purchases and resells physical infrastructure commodities.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -S$8.4 Million

According to IGC Pharma's latest financial reports the company's current earnings are S$1.18 Million. In 2025 the company made an earning of -S$6.84 Million, an increase over its 2024 earnings that were of -S$11.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$8.4 Million22.92%
2025 -S$6.84 Million-39.35%
2024 -S$11.27 Million-37.72%
2023 -S$18.09 Million1.19%
2022 -S$17.88 Million21.96%
2021 -S$14.66 Million27.13%
2020 -S$11.53 Million57.16%
2019 -S$7.34 Million85.47%
2018 -S$3.96 Million52.76%
2017 -S$2.59 Million-16.23%
2016 -S$3.1 Million-28.75%
2015 -S$4.34 Million-19.59%
2014 -S$5.4 Million6.79%
2013 -S$5.06 Million-9.47%
2012 -S$5.59 Million-74.03%
2011 -S$21.5 Million119.78%
2010 -S$9.78 Million62.02%
2009 -S$6.04 Million74.39%
2008 -S$3.47 Million-313.12%
2007 S$1.62 M-35.94%
2006 S$2.53 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
S$0.62 B-7,556.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
S$0.82 B-9,990.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
S$0.35 B-4,382.25%๐Ÿ‡บ๐Ÿ‡ธ USA